Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis
Same problem as FAERS and other reporting databases but way worse
This timing requirement becomes important when you're also using GLP-1 therapy, since GLP-1 medications can delay stomach emptying and alter how quickly nutrients and other medications move through your digestive system
On the flipside, take a random assortment of the lowest multiple companies: theyre likely described as undifferentiated products operating in increasingly competitive spaces
While these medications can aid in weight loss and glycemic control, combining them with healthy eating habits and regular physical activity enhances overall results